$0.01
3.90%
Nasdaq, Sep 25, 03:00 pm EDT. Closed.
ISIN
US30048L1044
Symbol
EVFM

Evofem Biosciences, Inc. Stock price

$0.01
+0.00 8.45% 1M
-0.00 9.41% 6M
-0.00 18.95% YTD
-0.01 43.80% 1Y
-0.13 94.50% 3Y
-1,484.24 100.00% 5Y
-13,161.37 100.00% 10Y
-134,999.99 100.00% 20Y
Nasdaq, Closing price Fri, Sep 25 2026
+0.00 0.00%
ISIN
US30048L1044
Symbol
EVFM
Industry

Is Evofem Biosciences, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
$1.0m
Enterprise Value
$51.7m
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
negative
P/S
0.1 | -
EV/Sales
2.9 | -
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
-
Return on Equity
-
ROCE
3.9%
ROIC
15.5%
Debt/Equity
-
Financials (TTM | estimate)
Revenue
$18.1m | -
EBITDA
$-2.5m
EBIT
$-2.8m
Net Income
$-15.5m
Free Cash Flow
$-480.0k
Growth (TTM | estimate)
Revenue
4.5% | -
EBITDA
29.8%
EBIT
38.8%
Net Income
-148.3%
Free Cash Flow
90.8%
Margin
Gross
75.5%
EBITDA
-13.9%
EBIT
-15.3%
Net
-86.0%
Free Cash Flow
-2.6%
More
EPS
$-0.1
FCF per Share
$0.0
Short interest
11.0%
Employees
32
Rev per Employee
$630.0k

Evofem Biosciences, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Evofem Biosciences, Inc. forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a Evofem Biosciences, Inc. forecast:

Hold
50%
Sell
50%

Financial data from Evofem Biosciences, Inc.

Jun '26
+/-
%
18 18
5% 5%
100%
- Direct Costs 4.42 4.42
26% 26%
24%
14 14
1% 1%
76%
- Selling and Administrative Expenses 16 16
22% 22%
89%
- Research and Development Expense 2.43 2.43
40% 40%
13%
-2.50 -2.50
30% 30%
-14%
- Depreciation and Amortization 0.26 0.26
73% 73%
1%
EBIT (Operating Income) EBIT -2.76 -2.76
39% 39%
-15%
Net Profit -16 -16
148% 148%
-86%

In millions USD.

Don't miss a Thing! We will send you all news about Evofem Biosciences, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Evofem Biosciences, Inc. Stock News

Neutral
Business Wire
●
2 days ago
SAN DIEGO--(BUSINESS WIRE)---- $EVFM #contraception--Women's health innovator Evofem Biosciences, Inc. (OTCID: EVFM) has achieved an important milestone in its strategy to support long-term growth, enhance manufacturing flexibility, and reduce costs. Evofem has contracted with a second pharmaceutical manufacturer to produce PHEXX® (lactic acid, citric acid and potassium bitartrate), its hormone...
Neutral
Business Wire
●
4 months ago
SAN DIEGO--(BUSINESS WIRE)---- $EVFM #BV--Women's health innovator Evofem Biosciences, Inc. (Evofem or the Company) (OTCID: EVFM), today announced financial results for the first quarter ended March 31, 2026. “Evofem continues to execute our strategy to increase revenues and to diversify and reduce risk in our revenue stream,” said Saundra Pelletier, CEO of Evofem. “A key component of this stra...
Neutral
Business Wire
●
5 months ago
SAN DIEGO--(BUSINESS WIRE)---- $EVFM #BV--Women's health innovator Evofem Biosciences, Inc. (OTCID: EVFM) (Evofem or the Company) today announced that it has entered into an exclusive Distribution Agreement with Clovis Davis Pharmaceuticals, LLC, a distributor of pharmaceutical and related products (Clovis Davis), to commercialize SOLOSEC® (secnidazole) 2g oral granules in sub-Saharan Africa (t...

Company Profile

Evofem Biosciences, Inc. develops therapeutic solutions to meet sexual and reproductive health needs of women. Its product include Amphora Contraceptive for the prevention of pregnancy, antimicrobial drug product for the prevention of sexually transmitted infections and Antimicrobial Drug product to prevent the reoccurrence of bacterial vaginosis. The company was founded in 2007 and is headquartered in San Diego, CA.

Head office United States
CEO Ms. Pelletier
Employees 32
Founded 2007
Website www.evofem.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today